ROBOF yields 2000000.00% · JNJ yields 2.13%● Live data
📍 ROBOF pulled ahead of the other in Year 1
Combined, ROBOF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ROBOF + JNJ for your $10,000?
RoboGroup T.E.K. Ltd. engages in the robotics, motion control, and technology education business in Israel. The company develops, manufactures, and markets training products and e-learning systems, as well as engineering and manufacturing technology training systems; and designs and implements technology laboratories for the education system. It also develops, markets, and distributes Coderz platform products, an experiential, gaming-based digital platform for science and virtual robotics competitions through virtual robots, programming languages, challenging arenas, and curricula designed for learners of various levels and ages in the general science and technology education, and home education markets. In addition, the company markets and sells products from third parties; and offers upgrading and installing services. It offers its products under the Intelitek, Robotec, and CoderZ brands. The company was formerly known as Eshed Robotec (1982) Ltd. The company was incorporated in 1982 and is based in Rosh HaAyin, Israel.
Full ROBOF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.